The Kaplan–Meier survival curves were graphed only for patients in the severe and critical COVID-19 groups, and they did not show a statistically significant difference between the high and low levels of IL-6, IL-10, and TNF-α at admission (Supplementary Figure S3). This evidence concerns the gene IL6 and COVID-19.